Stem Cell Research

  • Blogs

    November 6, 2009

    State Agency Grants Signal Shift Away from Embryonic Stem Cells

    In an April cover story, we looked at the dilemma facing the California Institute for Regenerative Medicine (CIRM), the state agency created through Proposition 71 to fund stem-cell research: Should the landmark agency direct the remainder of its $3 billion in research funds towards "adult" stem cel ... More >>

  • Blogs

    July 1, 2009

    Cell Divisions: A Rough Week for S.F.-Based Stem Cell Agency

    Tempest in a petri dishIt's been a tough week in the news for California's San Francisco-based stem-cell research agency.Last week, it was revealed that the California Institute for Regenerative Medicine (CIRM) -- created to fund stem-cell research through Proposition 71, the 2004 state ballot initi ... More >>

  • Blogs

    June 26, 2009

    Chief Scientific Officer Resigns from S.F.-Based State Stem Cell Agency

    Marie CseteThe chief scientific officer at California's stem-cell agency has announced that she will step down from her position in a little over a month.Marie Csete, who had been at the San Francisco-based California Institute for Regenerative Medicine (CIRM) for slightly more than a year, has so f ... More >>

  • Blogs

    June 15, 2009

    State Stem Cell Agency Chairman to Step Down

    Robert Klein, the Palo Alto real-estate magnate who led the successful 2004 ballot-initiative campaign to create a $3 billion state stem-cell funding agency and then steered the agency through its first years as chairman, has announced that he will step down from his leadership post at the end of 20 ... More >>

  • Blogs

    April 30, 2009

    State Stem Cell Agency Announces $275 Million from Bond Sales

    Help -- or at least cash -- is on the wayThe California Institute for Regenerative Medicine (CIRM) announced yesterday that it has received $275 million in fresh funding from a recent sale of state bonds, saving the state stem-cell agency from a cash crunch that would have left it without money to f ... More >>

  • News

    April 22, 2009
  • Blogs

    April 17, 2009

    Researchers Report Promising Results in Diabetes Stem-cell Treatment -- But Don't Say 'Breakthrough' Yet

    Keep those fingers crossedThe front line of advanced biomedical research doesn't stand still. Whether it's promising advances or devastating setbacks, this field of human knowledge is so young -- and so populated by bright and ambitious scientists and entrepreneurs -- that it seems news is always b ... More >>

  • News

    April 15, 2009
  • Blogs

    March 31, 2009

    After 146-Year Absence, 'Living Human Products' Back on U.S. Market

    Library of CongressFor sale once more?In 1863, Abraham Lincoln signed the Emancipation Proclamation, declaring illegal the sale, purchase, or ownership of living human products, known then as people.In 2009, Barack Obama signed an order lifting restrictions on federal funding of stem cell research,& ... More >>

  • Blogs

    January 26, 2009

    Money, Money, Money: S.F.'s Big Charitable Spenders

    In these dire financial times, fewer of us have the opportunity to donate to charity (at least, that's what we keep telling ourselves). But some really, really rich people are more than capable of forking over large quantities of the stuff, as evidenced by Slate's list of the largest charitable dona ... More >>

  • News

    July 27, 2005

    Onward, Christian Lawyers

    Why lawsuits filed by anti-abortion activists may be a blessing in disguise for the California stem cell institute

  • News

    October 9, 2002


    In S.F.'s political fight game, all the contestants are ignoring a national biotech debate that could put the local economy down for the count

  • News

    October 31, 2001

    Cell Therapy

    Bay Area researchers are using a particular cancer to produce neuronlike cells that, when injected into the brain, seem to reverse the effects of stroke. Is the treatment a historic medical breakthrough, or a reckless ploy to attract investors?

  • News

    June 30, 1999

    Science of the Lambs

    Buying Dolly the duplicated sheep has brought researchers at the Bay Area's Geron Corp. to the threshold of remarkable frontiers in transplants and cloning. Do we want to follow their lead?

©2014 SF Weekly, LP, All rights reserved.